Wuhan Thalys Med Tech Co Ltd (603716) — Free Cash Flow Generation Index
Wuhan Thalys Med Tech Co Ltd (603716) has a Free Cash Flow Generation Index of 0.97x as of September 2025. Free cash flow of CN¥53.00 Million represents 1% of operating cash flow (CN¥54.57 Million). See 603716 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wuhan Thalys Med Tech Co Ltd Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Wuhan Thalys Med Tech Co Ltd across 9 annual periods. Explore Wuhan Thalys Med Tech Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Wuhan Thalys Med Tech Co Ltd (2012–2024)
Year-by-year Free Cash Flow Generation Index for Wuhan Thalys Med Tech Co Ltd. For the full company profile including market capitalisation, see 603716 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.77x | CN¥76.39 Million | CN¥99.60 Million | CN¥23.21 Million | ▲ +13.5% |
| 2023 | 0.68x | CN¥85.06 Million | CN¥125.89 Million | CN¥40.83 Million | ▲ +171.6% |
| 2022 | -0.94x | CN¥-26.52 Million | CN¥28.12 Million | CN¥54.64 Million | ▲ +92.0% |
| 2020 | -11.84x | CN¥-117.76 Million | CN¥9.94 Million | CN¥127.70 Million | ▼ -43221.6% |
| 2019 | -0.03x | CN¥-2.57 Million | CN¥93.92 Million | CN¥96.49 Million | ▼ -122.4% |
| 2015 | 0.12x | CN¥5.64 Million | CN¥46.11 Million | CN¥40.47 Million | ▲ +320.5% |
| 2014 | -0.06x | CN¥-1.67 Million | CN¥30.07 Million | CN¥31.73 Million | ▲ +0.4% |
| 2013 | -0.06x | CN¥-1.81 Million | CN¥32.54 Million | CN¥34.35 Million | ▲ +99.6% |
| 2012 | -14.20x | CN¥-38.34 Million | CN¥2.70 Million | CN¥41.04 Million | — |